Whitepapers
This section of the website contains white papers that cover every facet of the pharmaceutical sector and deal with current topics, technology, research, etc. to provide readers with comprehensive information and expertise.
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
Tackling the Bioavailability Bottleneck in Oral Drug Development
Despite continued advances in medicinal chemistry and target biology failure rates in clinical drug development remain stubbornly high A significant proportion of late stage attrition can be traced back not to a lack of efficacy
Molecular Modeling and Data Science for De-risking and Cost- saving of Pharmaceutical Development
Advances in computational materials science and process simulation have made computational tools essential in drug development and manufacturing Integrating computational and experimental approaches helps derisk pharmaceutical development leading to significant time and cost savings
Nasal Delivery of Spray Dried Biologics: Opportunities and Challenges
Delivery via nasal rout offers a number of benefits over some of the traditional routes of administration for both small molecules and larger biologics Advantages include rapid delivery into the bloodstream avoidance of first pass metabolism the ability to selfadminister and the potential of direct delivery into the brainCNS
Critical Testing Strategies for Autoinjector Drug Products
As demand for selfadministered therapies accelerates autoinjectors formally known as automated needlebased injection systems NISAUTO are playing an increasingly central role in modern medicine
Advancements in Drug Safety and Pharmacovigilance Using AI and Generative AI(LLMs)
The white paper explores trends in adverse drug event reporting from the FDAs Adverse Event Reporting System FAERS over the past decade showing a marked increase in the volume and seriousness of reports Between and FAERS recorded
Pharma 4.0 Optimizing Manufacturing Operations through Digitalization
Industry also known as Smart Industry is becoming prevalent across various sectors including the pharmaceutical industry Technologies like the Internet of Things IoT cloud computing and automated data exchange are now integral to the industry This white paper explores the implications of Industry for pharma
Identifying Druggable Therapeutic Targets: Unveiling promising avenues in Drug Discovery
Determining the ability of a target to bind to a drug with high affinity to modulate its function with a therapeutic benefit could be termed Druggability It needs a nontrivial amount of time financial investment
